Current Study
Bronchiectasis | ATMOS
Study Overview
Location
Spearwood
Phase
Phase 2
Study Duration
Main Entry Criteria
Age & Health Diagnosis
Age: You must be between 18 and 80 years old.
Confirmed Diagnosis: You must have non-cystic fibrosis bronchiectasis (NCFB)—with symptoms like ongoing cough, daily mucus production, or frequent lung infections—confirmed by a high-resolution CT scan.
Sputum Sample: You must currently cough up mucus (sputum) daily and be able to provide a sample at your initial screening visit.
Medical History & Lung Function
Recent Flare-ups: You must have had at least 2 moderate-to-severe lung flare-ups in the past 12 months, OR 1 severe flare-up requiring hospitalization/IV antibiotics in the past 6 months.
Proper Technique: You must be able to demonstrate correct inhaler and breathing test techniques during screening.
Family Planning & Birth Control
Not Pregnant/Breastfeeding: Women cannot be pregnant, breastfeeding, or planning to become pregnant.
Contraception Agreement: Men and women of childbearing potential must agree to use approved birth control throughout the treatment period and for at least 60 days after the final dose (men must also refrain from donating sperm).
Main Exclusion Criteria
Other Lung Diseases & Treatments
Specific Types of Bronchiectasis: Your condition is caused by cystic fibrosis, lung fibrosis, severe immune deficiencies, or genetic conditions like alpha-1 antitrypsin deficiency.
Main Diagnosis of Asthma or COPD: Asthma or COPD is your primary (main) lung diagnosis, rather than a secondary condition.
Other Significant Lung Diseases: You have another major lung condition that the study doctor determines could pose a safety risk.
Lung Transplant: You have ever received a lung transplant.
Infections & Recent Illnesses
Tuberculosis (TB): You have active TB, untreated latent TB, a history of improperly treated TB, or are at high risk of catching TB.
Recent Infection or Flare-Up: You had an infection or lung flare-up requiring antibiotics, steroids, or antivirals within the 4 weeks before screening.
Ongoing/Serious Infections: You have a history of frequent, recurring infections or had a serious infection outside the lungs in the last 6 months.
Assessments
Lung & Breathing Tests
High-Resolution CT (HRCT) Scan: A chest scan evaluated by central experts to confirm the bronchiectasis diagnosis across lung lobes.
Spirometry Tests: Regular breathing tests (measured post-bronchodilator) to check forced expiratory volume and assess overall lung function capacity.
Sputum Sampling: Collection of spontaneously produced phlegm/mucus samples at initial screening.
Clinical & Safety Monitoring
Health & Physical Exams: Ongoing monitoring of vital signs, physical health, and medical history.
Electrocardiograms (ECG): Heart trace readings to ensure cardiovascular safety.
Laboratory Testing: Regular blood and urine panels, including absolute neutrophil counts (white blood cells) and screening for tuberculosis (TB) or other active infections.
Side Effect & Exacerbation Tracking: Continuous evaluation for any adverse events, safety issues, or sudden lung flare-ups (pulmonary exacerbations requiring antibiotics, steroids, or hospitalization).
Patient-Reported Outcomes & Quality of Life
Quality of Life Questionnaires: Surveys such as the QOL-B (Quality of Life Questionnaire-Bronchiectasis) to measure respiratory symptoms, daily functioning, and overall health status.
Inhaler & Technique Checks: Assessment of proper inhaler usage and spirometry breathing techniques.